{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:03Z","timestamp":1792785963371,"version":"4.5.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Amiens"},{"name":"University Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Therapeutic drug monitoring (TDM) contributes to optimizing exposure to \u03b2-lactam antibiotics. However, how excessive exposure to \u03b2-lactams can increase the burden of care of critically ill patients is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>In a prospective cohort study, we examined whether excessive \u03b2-lactam serum concentrations contribute to neurological deterioration and the associated complications of adult septic patients without recent history of neurological disease treated with \u03b2-lactams in a medical ICU. Excessive \u03b2-lactam concentrations were defined as serum concentrations that exceeded the upper limit of the therapeutic range recommended by the French Societies of Pharmacology and Therapeutics (SFPT) and Anesthesia and Intensive Care Medicine (SFAR). Neurological deterioration was defined as an increase in the neurological Sequential Organ Failure Assessment score (nSOFA) of \u22651 between the day of starting treatment at admission and the day of TDM performed 2 days after treatment initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 119 patients [median age: 65 years; males: 78 (65.5%)] admitted for acute respiratory distress [59 (49.6%)] or septic shock [25 (21%)]. In adjusted logistic regression analysis, an excessive \u03b2-lactam serum concentration was associated with neurological deterioration [OR (95% CI): 10.38 (3.23\u201333.35), P\u200a&amp;lt;\u200a0.0001]. Furthermore, in adjusted linear regression analysis, an excessive \u03b2-lactam serum concentration was associated with longer time to discharge alive (\u03b2=0.346, P\u200a=\u200a0.0007) and, among mechanically ventilated patients discharged alive, with longer time to extubation following the withdrawal of sedation (\u03b2=0.248, P\u200a=\u200a0.0030).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results suggest that excessive exposure to \u03b2-lactams could complicate the management of septic patients in the ICU and confirm the clinical relevance of the upper concentration limits recommended for dose reduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkad284","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T16:46:17Z","timestamp":1693845977000},"page":"2691-2695","source":"Crossref","is-referenced-by-count":23,"title":["Neurological burden and outcomes of excessive \u03b2-lactam serum concentrations of critically ill septic patients: a prospective cohort study"],"prefix":"10.1093","volume":"78","author":[{"given":"Yoann","family":"Zerbib","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, CHU Amiens-Picardie , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Gaulin","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, CHU Amiens-Picardie , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bodeau","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, CHU Amiens-Picardie , Amiens , France"},{"name":"MP3CV Laboratory, UR 7517, UPJV , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-7110","authenticated-orcid":false,"given":"Benjamin","family":"Batteux","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, CHU Amiens-Picardie , Amiens , France"},{"name":"MP3CV Laboratory, UR 7517, UPJV , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Lemaire-Hurtel","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, CHU Amiens-Picardie , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Maizel","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, CHU Amiens-Picardie , Amiens , France"},{"name":"MP3CV Laboratory, UR 7517, UPJV , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loay","family":"Kontar","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, CHU Amiens-Picardie , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0186-4797","authenticated-orcid":false,"given":"Youssef","family":"Bennis","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, CHU Amiens-Picardie , Amiens , France"},{"name":"MP3CV Laboratory, UR 7517, UPJV , Amiens , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"2023110823041470400_dkad284-B1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.medmal.2015.10.001","article-title":"Antibiotic use and good practice in 314 French hospitals: the 2010 SPA2 prevalence study","volume":"45","author":"Alfandari","year":"2015","journal-title":"Med Mal Infect"},{"key":"2023110823041470400_dkad284-B2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to \u03b2-lactam antibiotics: a literature review","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf"},{"key":"2023110823041470400_dkad284-B3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database","volume":"398","author":"Lacroix","year":"2019","journal-title":"J Neurol Sci"},{"key":"2023110823041470400_dkad284-B4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13054-018-2262-z","article-title":"Antimicrobial exposure and the risk of delirium in critically ill patients","volume":"22","author":"Grahl","year":"2018","journal-title":"Crit Care"},{"key":"2023110823041470400_dkad284-B5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2013concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"2023110823041470400_dkad284-B6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients\u2014guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique\u2014SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et R\u00e9animation\u2014SFAR)","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"key":"2023110823041470400_dkad284-B7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of \u03b2-lactams in critically ill patients: proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2023110823041470400_dkad284-B8","first-page":"497","article-title":"Elevated \u03b2-lactam concentrations associated with neurological deterioration in ICU septic patients","volume":"81","author":"Beumier","year":"2015","journal-title":"Minerva Anestesiol"},{"key":"2023110823041470400_dkad284-B9","doi-asserted-by":"crossref","first-page":"e00654-17","DOI":"10.1128\/AAC.00654-17","article-title":"Neurotoxic concentration of piperacillin during continuous infusion in critically ill patients","volume":"61","author":"Quinton","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2023110823041470400_dkad284-B10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2023110823041470400_dkad284-B11","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: a retrospective study of \u03b2-lactam concentration\u2013toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"\u2013","key":"2023110823041470400_dkad284-B12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2023110823041470400_dkad284-B13","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2023110823041470400_dkad284-B14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CCM.0000000000001375","article-title":"Validity of a modified sequential organ failure assessment score using the Richmond Agitation-Sedation Scale","volume":"44","author":"Vasilevskis","year":"2016","journal-title":"Crit Care Med"},{"key":"2023110823041470400_dkad284-B15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11910-016-0651-8","article-title":"Neurologic complications in the intensive care unit","volume":"16","author":"Rubinos","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2023110823041470400_dkad284-B16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00003246-199301000-00019","article-title":"Neurologic complications of critical medical illnesses","volume":"21","author":"Bleck","year":"1993","journal-title":"Crit Care Med"},{"key":"2023110823041470400_dkad284-B17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00134-017-4807-z","article-title":"Potentially modifiable factors contributing to sepsis-associated encephalopathy","volume":"43","author":"Sonneville","year":"2017","journal-title":"Intensive Care Med"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/11\/2691\/52814384\/dkad284.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/78\/11\/2691\/52814384\/dkad284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:04:38Z","timestamp":1699466678000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/78\/11\/2691\/7267578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2023,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkad284","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,9,11]]}}}